SER AMEX
Serina Therapeutics, Inc.
1W: +11.1%
1M: -2.0%
3M: +17.9%
YTD: -8.2%
1Y: -66.5%
3Y: -90.3%
5Y: -95.5%
$1.98
+0.09 (+4.93%)
Weekly Expected Move ±10.0%
$1
$1
$2
$2
$2
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$21.4M
52W Range1.22-7.92
Volume194,410
Avg Volume3,284,058
Beta1.15
Dividend—
Analyst Ratings
Company Info
CEOSteven A. Ledger
Employees12
SectorHealthcare
IndustryBiotechnology
IPO Date2000-01-21
Websiteserinatherapeutics.com
601 Genome Way
Huntsville, AL 35806
US
Huntsville, AL 35806
US
256 327 9630
About Serina Therapeutics, Inc.
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson's disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson's disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Latest News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Serina Therapeutics wins NYSE approval; 2027 listing compliance deadline set
Serina Therapeutics GAAP EPS of -$1.91, revenue of $0.13M
12 Health Care Stocks Moving In Wednesday's Intraday Session
12 Health Care Stocks Moving In Tuesday's Intraday Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Marshall Richard Pet | P-Purchase | 12,183 | $1.65 | 2026-05-19 |
| Bailey Gregory | A-Award | 59,667 | $1.94 | 2026-03-31 |
| Venkatesan Jay | A-Award | 7,553 | $1.94 | 2026-03-31 |
| Moreadith Randall | S-Sale | 6,500 | $2.86 | 2026-03-23 |
| Moreadith Randall | M-Exempt | 6,500 | $0.06 | 2026-03-23 |